(Q38742769)

6 September 2017

title

Gut Microbiota of Nonalcoholic Fatty Liver Disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

6 September 2017

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26898658%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Lixin Zhu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26898658%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Robert D Baker

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26898658%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Susan S Baker

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26898658%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

22 February 2016

1 reference

Digestive Diseases and Sciences

6 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26898658%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26898658%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26898658%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

1268-1281

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26898658%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10620-016-4045-1

13 June 2020

exact match

0 references

cites work

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Gut Microbiota in Health and Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

A human gut microbial gene catalogue established by metagenomic sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

The gut microbiota as an environmental factor that regulates fat storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Gut microbiota from twins discordant for obesity modulate metabolism in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Diversity of the human intestinal microbial flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

A metagenome-wide association study of gut microbiota in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Gut microbiome and nonalcoholic fatty liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Richness of human gut microbiome correlates with metabolic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Dietary intervention impact on gut microbial gene richness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

The abundance and variety of carbohydrate-active enzymes in the human gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

A Genomic View of the Human-Bacteroides thetaiotaomicron Symbiosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Modulation of the fecal bile acid profile by gut microbiota in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Microbiota and SCFA in lean and overweight healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis--a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Colonic health: fermentation and short chain fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Gut hormone PYY(3-36) physiologically inhibits food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Inhibition of food intake in obese subjects by peptide YY3-36

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Role of phosphatidylcholine biosynthesis in the regulation of lipoprotein homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Endogenous formation of dimethylamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Mono-, di- and trimethylamine in human gastric fluid: potential substrates for nitrosodimethylamine formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Role of metabolism in dimethylnitrosamine-induced immunosuppression: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Does fructose consumption contribute to non-alcoholic fatty liver disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Effects on uric acid, body mass index and blood pressure in adolescents of consuming beverages sweetened with high-fructose corn syrup

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Nuclear receptor atlas of female mouse liver parenchymal, endothelial, and Kupffer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Bile acids as regulators of hepatic lipid and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

TGR5-mediated bile acid sensing controls glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Systemic gut microbial modulation of bile acid metabolism in host tissue compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

A G protein-coupled receptor responsive to bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Non-alcoholic Fatty liver disease: the bile Acid-activated farnesoid x receptor as an emerging treatment target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Bile acid receptors as targets for drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Role of alcohol metabolism in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Acetaldehyde disrupts tight junctions and adherens junctions in human colonic mucosa: protection by EGF and L-glutamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Metabolic endotoxemia initiates obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Elevated endotoxin levels in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Toll-like receptors as targets in chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

TLR4 enhances TGF-beta signaling and hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Role of TLR9 in hepatic stellate cells and experimental liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Toll-like receptors: critical proteins linking innate and acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Recognition of pathogen-associated molecular patterns by TLR family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Bile acid is a host factor that regulates the composition of the cecal microbiota in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Intestinal microbiota in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4045-1

Anaerobic dissimilation of glucose-C14 by Escherichia coli

21 January 2018

1 reference

12 December 2020

Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study

1 reference

12 December 2020

Increased sensitivity to endotoxemia in the bile duct-ligated cirrhotic Rat

1 reference

12 December 2020

Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial

1 reference

12 December 2020

Attenuation of CCl(4)-induced hepatic fibrosis by GdCl(3) treatment or dietary glycine

1 reference

12 December 2020

Energy intake is associated with endotoxemia in apparently healthy men.

1 reference

12 December 2020

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

1 reference

12 December 2020

Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity

1 reference

12 December 2020

Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production

1 reference

12 December 2020

Conversion of dietary choline to trimethylamine and dimethylamine in rats: dose-response relationship

1 reference

12 December 2020

Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage

1 reference

12 December 2020

Novel evidence for chronic exposure to endotoxin in human nonalcoholic steatohepatitis

1 reference

12 December 2020

Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake

1 reference

12 December 2020

Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease.

1 reference

12 December 2020

Parenteral nutrition supplemented with short-chain fatty acids: effect on the small-bowel mucosa in normal rats

1 reference

12 December 2020

Short-chain fatty acid-supplemented total parenteral nutrition enhances functional adaptation to intestinal resection in rats

1 reference

12 December 2020

Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice

1 reference

12 December 2020

Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients

1 reference

12 December 2020

Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis

1 reference

12 December 2020

Studies of metabolites in diarrheal stool specimens containing Shigella species by frequency-pulsed electron capture gas-liquid chromatography

1 reference

12 December 2020

Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease

1 reference

12 December 2020

Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD)

1 reference

12 December 2020

The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

1 reference

12 December 2020

Biliary lactoferrin concentrations are increased in active inflammatory bowel disease: a factor in the pathogenesis of primary sclerosing cholangitis?

1 reference

12 December 2020

The formation of ethanol in Escherichia coli

1 reference

12 December 2020

Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation

1 reference

12 December 2020

Effects of Lactobacillus rhamnosus Strain GG in Pediatric Obesity-related Liver Disease

1 reference

12 December 2020

Intakes and sources of dietary fiber in the British population1

1 reference

12 December 2020

Treatment of distal ulcerative colitis with short-chain fatty acid enemas. A placebo-controlled trial. German-Austrian SCFA Study Group

1 reference

12 December 2020

Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides

1 reference

12 December 2020

The contribution of the large intestine to energy supplies in man

1 reference

12 December 2020

Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women

1 reference

12 December 2020

Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation

1 reference

12 December 2020